Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. Hematology Am Soc Hematol Educ Program. 2012; 2012:444-9.
-
Adolescent
-
Adolescent
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Monoclonal, Murine-Derived
-
Child
-
Child
-
Child, Preschool
-
Child, Preschool
-
Hematology
-
Hematology
-
Hemorrhage
-
Hemorrhage
-
Humans
-
Humans
-
Immunosuppressive Agents
-
Immunosuppressive Agents
-
Infant
-
Infant
-
Pediatrics
-
Pediatrics
-
Purpura, Thrombocytopenic, Idiopathic
-
Purpura, Thrombocytopenic, Idiopathic
-
Recombinant Proteins
-
Recombinant Proteins
-
Rituximab
-
Rituximab
-
Splenectomy
-
Splenectomy
-
Thrombocytopenia
-
Thrombocytopenia
-
Thrombopoietin
-
Thrombopoietin
-
Treatment Outcome
-
Treatment Outcome